ESTRO Brachytherapy for Prostate Cancer 2018
What is your preferred management for a patient aged 66 years presenting with a PSA of 13.6, Gleason score 4+3 prostate cancer which is stage T3a on MR staging? He has no significant co-morbidities
A. Radical prostatectomy B. Active surveillance C. External beam IMRT to 78Gy with ADT D. LDR seed brachytherapy with ADT E. External beam IMRT + HDR boost
www.responseware.eu – ID: BT2018
Made with FlippingBook - Online catalogs